The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-24
DOI
10.1038/s41598-017-14733-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Internal Pudental Artery Dysfunction in Diabetes Mellitus Is Mediated by NOX1-Derived ROS-, Nrf2-, and Rho Kinase–Dependent MechanismsNovelty and Significance
- (2016) Rhéure Alves-Lopes et al. HYPERTENSION
- Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases
- (2015) Tharmarajan Ramprasath et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase
- (2015) Jed W. Fahey et al. PLoS One
- Nrf2-mediated redox signalling in vascular health and disease
- (2014) Giovanni E. Mann FREE RADICAL BIOLOGY AND MEDICINE
- Sulforaphane Attenuation of Type 2 Diabetes-Induced Aortic Damage Was Associated with the Upregulation of Nrf2 Expression and Function
- (2014) Yonggang Wang et al. Oxidative Medicine and Cellular Longevity
- Combating oxidative stress in diabetic complications with Nrf2 activators: How much is too much?
- (2014) Sih Min Tan et al. REDOX REPORT
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Endothelial dysfunction — A major mediator of diabetic vascular disease
- (2013) Cristina M. Sena et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes
- (2013) Gopal V. Velmurugan et al. CARDIOVASCULAR RESEARCH
- Pyridoxamine Reverts Methylglyoxal-induced Impairment of Survival Pathways During Heart Ischemia
- (2013) Filipa Almeida et al. Cardiovascular Therapeutics
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- Dietary Nrf2 activators inhibit atherogenic processes
- (2012) Bernhard H.J. Juurlink ATHEROSCLEROSIS
- Crosstalk between Nrf2 and the proteasome: Therapeutic potential of Nrf2 inducers in vascular disease and aging
- (2012) Sarah J. Chapple et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Metabolic Effects of Sulforaphane Oral Treatment in Streptozotocin-Diabetic Rats
- (2012) Carolina Guerini de Souza et al. JOURNAL OF MEDICINAL FOOD
- Methylglyoxal promotes oxidative stress and endothelial dysfunction
- (2012) Cristina M. Sena et al. PHARMACOLOGICAL RESEARCH
- Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation
- (2011) Mingzhan Xue et al. BIOCHEMICAL JOURNAL
- Metformin restores endothelial function in aorta of diabetic rats
- (2011) Cristina M Sena et al. BRITISH JOURNAL OF PHARMACOLOGY
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo
- (2011) Y. Tan et al. DIABETES
- Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway
- (2010) Kyu Yeon Hur et al. ATHEROSCLEROSIS
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation
- (2010) Gerasimos P Sykiotis et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Protective effect of sulforaphane against oxidative stress: Recent advances
- (2010) Carlos Enrique Guerrero-Beltrán et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Antioxidants in Cardiovascular Health and Disease: Key Lessons from Epidemiologic Studies
- (2008) Bradley J. Willcox et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Role of the Amadori Product in the Complications of Diabetes
- (2008) Vincent M. Monnier et al. Annals of the New York Academy of Sciences
- Nrf2 Regulates Antioxidant Gene Expression Evoked by Oxidized Phospholipids in Endothelial Cells and Murine Arteries In Vivo
- (2008) Henna-Kaisa Jyrkkänen et al. CIRCULATION RESEARCH
- Activation of NF-E2-Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
- (2008) M. Xue et al. DIABETES
- Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation
- (2008) Camelia A. Danilov et al. GLIA
- The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
- (2008) Su-Yen Goh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of α-lipoic acid on endothelial function in aged diabetic and high-fat fed rats
- (2007) C M Sena et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse
- (2005) Hong Ding et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started